MASH – perVial.com

Posted on August 28, 2026 by pervial

Tirzepatide in Emerging Indications: Liver, Kidney, and Cardiovascular Research

3D visualization of dual incretin peptide receptor interaction with surrounding cellular structures.

While approved for diabetes and weight management, tirzepatide is under active investigation for broader cardiometabolic indications. Emerging clinical tri

Read more Tirzepatide in Emerging Indications: Liver, Kidney, and Cardiovascular Research

Posted on August 23, 2026 by pervial

Survodutide: Mechanism of Action and Clinical Trial Evidence

3D scientific rendering of dual GLP-1 and glucagon receptor activation by peptide ligand survodutide

An evidence-based scientific review of survodutide (BI 456906), exploring its dual GLP-1 and glucagon receptor agonism, Phase 2 trial results in MASH and o

Read more Survodutide: Mechanism of Action and Clinical Trial Evidence